ドイツのジェネリック医薬品産業プロファイルでは、市場規模（2018〜2023年の値、および2028年までの予測）などのトップラインの定性的および定量的概要情報が提供されます。プロファイルには、主要な財務指標や市場内の競争圧力の分析など、主要企業の説明も含まれています。
目次
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Has the government recently implemented any initiatives aimed at boosting the market?
8 Company Profiles
8.1. Teva Pharmaceutical Industries Ltd
8.2. Novartis AG
8.3. Bayer AG
8.4. Stada Arzneimittel AG
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Germany generics market value: $ million, 2018-23
Table 2: Germany generics market volume: % of total pharma volume, 2018-23
Table 3: Germany generics market geography segmentation: $ million, 2023
Table 4: Germany generics market value forecast: $ million, 2023-28
Table 5: Germany generics market volume forecast: % of total pharma volume, 2023-28
Table 6: Teva Pharmaceutical Industries Ltd: Key Facts
Table 7: Teva Pharmaceutical Industries Ltd: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Ltd: Key Employees
Table 9: Novartis AG: Key Facts
Table 10: Novartis AG: Annual Financial Ratios
Table 11: Novartis AG: Key Employees
Table 12: Bayer AG: Key Facts
Table 13: Bayer AG: Annual Financial Ratios
Table 14: Bayer AG: Key Employees
Table 15: Bayer AG: Key Employees Continued
Table 16: Bayer AG: Key Employees Continued
Table 17: Stada Arzneimittel AG: Key Facts
Table 18: Stada Arzneimittel AG: Key Employees
Table 19: Germany Size of Population (million), 2019-23
Table 20: Germany Real GDP (Constant 2010 Prices, $ Billion) 2019-23
Table 21: Germany GDP (Current Prices, $ Billion), 2019-23
Table 22: Germany Inflation, 2019-23
Table 23: Germany Consumer Price Index (Absolute), 2019-23
Table 24: Germany Exchange Rate, 2018-23
List of Figures
Figure 1: Germany generics market value: $ million, 2018-23
Figure 2: Germany generics market volume: % of total pharma volume, 2018-23
Figure 3: Germany generics market geography segmentation: % share, by value, 2023
Figure 4: Germany generics market value forecast: $ million, 2023-28
Figure 5: Germany generics market volume forecast: % of total pharma volume, 2023-28
Figure 6: Forces driving competition in the generics market in Germany, 2023
Figure 7: Drivers of buyer power in the generics market in Germany, 2023
Figure 8: Drivers of supplier power in the generics market in Germany, 2023
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Germany, 2023
Figure 10: Factors influencing the threat of substitutes in the generics market in Germany, 2023
Figure 11: Drivers of degree of rivalry in the generics market in Germany, 2023
